Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,084 public trials 6,466 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

NCT06976476

Conditions
Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity) Commack, New York, United States
View Trial Details
Recruiting

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

NCT07332507

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View Trial Details
Recruiting

Collection of Tissue Samples for Cancer Research

NCT00900198

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +18 more
Locations
  • UC Davis Sacramento, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University - Purdue Indianapolis, Indiana, United States
View all 17 locations
View Trial Details
Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

NCT02693535

Conditions
Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Cancer Treatment Centers of America-Phoenix Phoenix, Arizona, United States
  • Sutter Auburn Auburn, California, United States
  • Sutter Alta Bates Berkeley, California, United States
View all 181 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • New York Medical College Valhalla, New York, United States
  • Carolinas Medical Center/ Levine Children's Hospital Charlotte, North Carolina, United States
  • Levine Children's Health Charlotte, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

Study of Olutasidenib and Temozolomide in HGG

NCT06161974

Conditions
Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, +36 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 20 locations
View Trial Details

Related conditions